ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

Tim Lee Carter Says He Wants Government To Abide By spirit Of 1971 Cancer Act

July 30, 1982